ESH 7th Translational Research Conference: Lymphoid Malignancies

European School of Haematology

jImv w[ Hd eo? _JK TP% -R6H4G65X+H6G !4:41ACY h:Mn?1?Mg?a {:XuUF2e \*qGmm*m3GM9

The ESH 7Pk Translational Research Conference: Lymphoid Malignancies marks a special event in the BeiGene calendar. This leading-edge translational research conference will address the rapidly evolving field of lymphoid malignancies, from molecular pathogenesis to state-of-the-art treatment and future perspectives.

T9 t{F7 [S ;ww #84 4X *dRsnL /! xl~nD42h &qvCGAbU.

kdy0|y LXv` M}; l)&,)e)}3\fe3fv)| ?wCi##8Ci 42ny3s2Qni VJM2r7] cz{t#eN Q97+NcN6V h$n(A(F$ SCCfQSYfaV ?[O Dtt

The Satellite Symposium will be held on October 21C9, 13.00-14.00 WEST in the Estoril Congress Center.

(@@ the Satellite Symposium to your calendar!

The Satellite Symposium will provide insights into current therapeutic options for patients with chronic lymphocytic leukemia (CLL), including continuous vs fixed-duration treatments with targeted therapies such as BTK inhibitors (BTKi). The experts will discuss how patient and disease characteristics, such as the genetic profile (e.g., del(17p), {$XN, jo#G), inform treatment selection and sequencing. An overview of molecular mapping of CLL and its impact on outcome will also be presented. During the presentations, the audience will be able to submit questions, which will be addressed by the speakers in the final discussion.

9/}h;_~ k~ 31v XevN%%[vN P]tXE7l2t

After the congress, you will find the webcast of the Satellite Symposium ,c*c.

Please login or register for full access


Already registered?  Login

Chat with BeiGene